Patients
Take Action For The International Thalassaemia Day 2021
Actualités
il y a 1 semaine
Take Action For The International Thalassaemia Day 2021
INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY »Addressing Health Inequalities Across the Global Thalassaemia Community » Each year, individuals around the globe band together for one day of pure and empowering…
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
Actualités
il y a 1 semaine
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
Hemanext Inc. announced today it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the…
The International Thalassaemia Day 2021 Official Page is Now Live!
Actualités
il y a 2 semaines
The International Thalassaemia Day 2021 Official Page is Now Live!
INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY »Addressing Health Inequalities Across the Global Thalassaemia Community » Visit the International Thalassaemia Day page, now LIVE on TIF website, to find out why…
Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?
Actualités
il y a 4 semaines
Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?
According to recent data released by the American Red Cross, in the first week of March 2021 more than 20% of blood donations from unvaccinated people in the US had…
COMING UP: New TIF Webinar On »COVID-19 Vaccinations & Patients With Haemoglobin Disorders »
Actualités
mars 19, 2021
COMING UP: New TIF Webinar On »COVID-19 Vaccinations & Patients With Haemoglobin Disorders »
TIF is delighted to inform you that a Special Webinar on ‘’COVID-19 Vaccinations & Patients with Haemoglobin Disorders’’ will take place on Wednesday, 31 March 2021, at 14:30-16:00 EEST/12:30-14:00 GMT.…
A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic
Actualités
mars 18, 2021
A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic
The expansion of management options and therapies for patients with thalassaemia is nowadays a reality, thanks to the application of new, revolutionary scientific procedures. However, patients’ understanding on the distinct…
Out Now: The Latest Issue of TIF’s COVID-19 Vaccinations Update
Actualités de TIF
mars 9, 2021
Out Now: The Latest Issue of TIF’s COVID-19 Vaccinations Update
Everything you need to know about the different COVID-19 vaccines, both already available and developing, in one place! Discover our newly updated Guide ”Vaccinations & Therapeutic Drugs for COVID-19”, containing a…
TIF’s Submission To The UK NICE’s Consultation Document For Zynteglo®
Actualités
mars 2, 2021
TIF’s Submission To The UK NICE’s Consultation Document For Zynteglo®
On February 12, in an appraisal consultation document, the UK National Institute for Health and Care Excellence (NICE) recommended against the use of Bluebird Bio’s Zynteglo (betibeglogene autotemcel) gene therapy for the…
Time To Get Ready For Rare Disease Day 2021!
Actualités
février 24, 2021
Time To Get Ready For Rare Disease Day 2021!
TIF joins forces with 300 million people around the world for the global observance of Rare Disease Day, coming up on February 28th. Rare Disease Day is an annual awareness…
TIF’s Public Statement on Current Developments in Gene Therapy SCD Clinical Trials and Thalassaemia Gene Therapy Zynteglo
Actualités
février 20, 2021
TIF’s Public Statement on Current Developments in Gene Therapy SCD Clinical Trials and Thalassaemia Gene Therapy Zynteglo
The Thalassaemia International Federation (TIF) has been informed through official communication by both the European Medicines Agency (EMA) and bluebird bio that the latter has placed Phase 1/2 and Phase…